Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study.

Guiard E, Lelievre B, Rouyer M, Zerbib F, Diquet B, Mégraud F, Tison F, Bignon E, Lassalle R, Droz-Perroteau C, Moore N, Blin P.

Drug Saf. 2019 May 8. doi: 10.1007/s40264-019-00821-6. [Epub ahead of print]

PMID:
31069703
2.

Real-World Outcomes with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema: 12-Month Results from the 36-Month BOREAL-DME Study.

Massin P, Creuzot-Garcher C, Kodjikian L, Girmens JF, Delcourt C, Fajnkuchen F, Glacet-Bernard A, Guillausseau PJ, Ponthieux A, Blin P, Grelaud A.

Ophthalmic Res. 2019 Mar 29:1-10. doi: 10.1159/000497406. [Epub ahead of print]

PMID:
30928985
3.

Biofilm-Constructing Variants of Paraburkholderia phytofirmans PsJN Outcompete the Wild-Type Form in Free-Living and Static Conditions but Not In Planta.

Rondeau M, Esmaeel Q, Crouzet J, Blin P, Gosselin I, Sarazin C, Pernes M, Beaugrand J, Wisniewski-Dyé F, Vial L, Faure D, Clément C, Ait Barka E, Jacquard C, Sanchez L.

Appl Environ Microbiol. 2019 May 16;85(11). pii: e02670-18. doi: 10.1128/AEM.02670-18. Print 2019 Jun 1.

PMID:
30902863
4.

Six-year survival study after myocardial infarction: The EOLE prospective cohort study. Long-term survival after MI.

Droz-Perroteau C, Blin P, Dureau-Pournin C, Thomas D, Danchin N, Tricoire J, Paillard F, Hercberg S, Guize L, Guiard E, Maïzi H, Bernard MA, Bénichou J, Moore N.

Therapie. 2019 Feb 25. pii: S0040-5957(19)30032-0. doi: 10.1016/j.therap.2019.02.001. [Epub ahead of print]

PMID:
30878144
5.

Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database.

Blin P, Dureau-Pournin C, Benichou J, Bonello L, Dallongeville J, Danchin N, Falissard B, Thomas-Delecourt F, Jové J, Lassalle R, Droz C, Moore N.

Atherosclerosis. 2019 Feb;281:98-106. doi: 10.1016/j.atherosclerosis.2018.11.037. Epub 2018 Dec 7.

PMID:
30658197
6.

Common and distinctive adaptive traits expressed in Dickeya dianthicola and Dickeya solani pathogens when exploiting potato plant host.

Raoul des Essarts Y, Pédron J, Blin P, Van Dijk E, Faure D, Van Gijsegem F.

Environ Microbiol. 2019 Mar;21(3):1004-1018. doi: 10.1111/1462-2920.14519. Epub 2019 Jan 27.

PMID:
30618082
7.

Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: A nationwide database cohort study.

Blin P, Samama CM, Sautet A, Benichou J, Lignot-Maleyran S, Lamarque S, Lorrain S, Lassalle R, Droz-Perroteau C, Mismetti P, Moore N.

Pharmacol Res. 2019 Mar;141:201-207. doi: 10.1016/j.phrs.2018.12.018. Epub 2018 Dec 21.

PMID:
30583081
8.

Comparative Effectiveness and Safety of Standard or Reduced Dose Dabigatran vs. Rivaroxaban in Nonvalvular Atrial Fibrillation.

Blin P, Dureau-Pournin C, Cottin Y, Bénichou J, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.

Clin Pharmacol Ther. 2019 Jun;105(6):1439-1455. doi: 10.1002/cpt.1318. Epub 2019 Feb 6.

PMID:
30499605
9.

Pharmacoepidemiology of non-steroidal anti-inflammatory drugs.

Moore N, Duong M, Gulmez SE, Blin P, Droz C.

Therapie. 2019 Apr;74(2):271-277. doi: 10.1016/j.therap.2018.11.002. Epub 2018 Nov 8.

PMID:
30477749
10.

Effectiveness and safety of 110 or 150 mg dabigatran vs. vitamin K antagonists in nonvalvular atrial fibrillation.

Blin P, Dureau-Pournin C, Cottin Y, Bénichou J, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.

Br J Clin Pharmacol. 2019 Feb;85(2):432-441. doi: 10.1111/bcp.13815. Epub 2018 Dec 16.

PMID:
30423205
11.

Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database.

Bosco-Lévy P, Duret S, Picard F, Dos Santos P, Puymirat E, Gilleron V, Blin P, Chatellier G, Looten V, Moore N.

Pharmacoepidemiol Drug Saf. 2019 Feb;28(2):194-200. doi: 10.1002/pds.4690. Epub 2018 Nov 5.

PMID:
30395375
12.

An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France.

Blin P, Demoly P, Drouet M, Falissard B, Lignot-Maleyran S, Maizi H, Lorrain S, Lassalle R, Droz-Perroteau C, Moore N, Molimard M.

Allergy Asthma Clin Immunol. 2018 Sep 24;14:38. doi: 10.1186/s13223-018-0262-9. eCollection 2018.

13.

Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample.

Duong M, Abouelfath A, Lassalle R, Droz C, Blin P, Moore N.

Drug Saf. 2018 Nov;41(11):1049-1058. doi: 10.1007/s40264-018-0686-7.

PMID:
29797240
14.

Complete Chromosome and Plasmid Sequences of Two Plant Pathogens, Dickeya solani Strains D s0432-1 and PPO 9019.

Khayi S, Blin P, Chong TM, Chan KG, Faure D.

Genome Announc. 2018 Apr 26;6(17). pii: e00233-18. doi: 10.1128/genomeA.00233-18.

15.

Complete Genome Sequences of the Plant Pathogens Dickeya solani RNS 08.23.3.1.A and Dickeya dianthicola RNS04.9.

Khayi S, Blin P, Chong TM, Robic K, Chan KG, Faure D.

Genome Announc. 2018 Jan 25;6(4). pii: e01447-17. doi: 10.1128/genomeA.01447-17.

16.

Management and 3-month outcomes of isolated superficial vein thrombosis of the lower limb: A real-world cohort study.

Blin P, Sevestre MA, Pouchain D, Gillet JL.

Thromb Res. 2017 Sep;157:117-119. doi: 10.1016/j.thromres.2017.07.009. Epub 2017 Jul 12. No abstract available.

PMID:
28734157
17.

The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.

Bezin J, Duong M, Lassalle R, Droz C, Pariente A, Blin P, Moore N.

Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):954-962. doi: 10.1002/pds.4233. Epub 2017 May 24.

PMID:
28544284
18.

Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database.

Blin P, Dureau-Pournin C, Lassalle R, Jové J, Thomas-Delecourt F, Droz-Perroteau C, Danchin N, Moore N.

Br J Clin Pharmacol. 2017 Sep;83(9):2056-2065. doi: 10.1111/bcp.13291. Epub 2017 May 5.

19.

Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study.

Overbeek JA, Heintjes EM, Prieto-Alhambra D, Blin P, Lassalle R, Hall GC, Lapi F, Bianchini E, Hammar N, Bezemer ID, Herings RMC.

Clin Ther. 2017 Apr;39(4):759-770. doi: 10.1016/j.clinthera.2017.02.008. Epub 2017 Mar 23.

PMID:
28342563
20.

[Costs of healthcare resource consumption after a myocardial infarction in France: An estimate from a medicoadministrative database (GSB)].

Philippe F, Blin P, Bouée S, Laurendeau C, Torreton E, Gourmelin J, Velkovski-Rouyer M, Levy-Bachelot L, Steg G.

Ann Cardiol Angeiol (Paris). 2017 Apr;66(2):74-80. doi: 10.1016/j.ancard.2016.12.004. Epub 2017 Jan 27. French.

PMID:
28139200
21.

Complete genome anatomy of the emerging potato pathogen Dickeya solani type strain IPO 2222T.

Khayi S, Blin P, Chong TM, Chan KG, Faure D.

Stand Genomic Sci. 2016 Nov 29;11:87. eCollection 2016.

22.

Pharmacological treatments of cardiovascular diseases: Evidence from real-life studies.

Salvo F, Bezin J, Bosco-Levy P, Letinier L, Blin P, Pariente A, Moore N.

Pharmacol Res. 2017 Apr;118:43-52. doi: 10.1016/j.phrs.2016.08.006. Epub 2016 Aug 5. Review.

PMID:
27503762
23.

Impact of a public media event on the use of statins in the French population.

Bezin J, Francis F, Nguyen NV, Robinson P, Blin P, Fourrier-Réglat A, Pariente A, Moore N.

Arch Cardiovasc Dis. 2017 Feb;110(2):91-98. doi: 10.1016/j.acvd.2016.05.002. Epub 2016 Jul 26.

24.

Outcomes following acute hospitalised myocardial infarction in France: An insurance claims database analysis.

Blin P, Philippe F, Bouée S, Laurendeau C, Torreton E, Gourmelin J, Leproust S, Levy-Bachelot L, Steg PG.

Int J Cardiol. 2016 Sep 15;219:387-93. doi: 10.1016/j.ijcard.2016.06.102. Epub 2016 Jun 23.

PMID:
27372604
25.

Using big data from health records from four countries to evaluate chronic disease outcomes: a study in 114 364 survivors of myocardial infarction.

Rapsomaniki E, Thuresson M, Yang E, Blin P, Hunt P, Chung SC, Stogiannis D, Pujades-Rodriguez M, Timmis A, Denaxas SC, Danchin N, Stokes M, Thomas-Delecourt F, Emmas C, Hasvold P, Jennings E, Johansson S, Cohen DJ, Jernberg T, Moore N, Janzon M, Hemingway H.

Eur Heart J Qual Care Clin Outcomes. 2016 Jul 1;2(3):172-183. doi: 10.1093/ehjqcco/qcw004.

26.

Usage patterns of paracetamol in France.

Duong M, Gulmez SE, Salvo F, Abouelfath A, Lassalle R, Droz C, Blin P, Moore N.

Br J Clin Pharmacol. 2016 Aug;82(2):498-503. doi: 10.1111/bcp.12957. Epub 2016 May 18.

27.

Increased Costs Due To Myocardial Infarction (Mi) In France: An Observational Analysis Using A Claims Database.

Blin P, Philippe F, Laurendeau C, Bouee S, Gourmelen J, Levy Bachelot L, Leproust S, Steg PG.

Value Health. 2015 Nov;18(7):A386. doi: 10.1016/j.jval.2015.09.841. Epub 2015 Oct 20. No abstract available.

28.

Incidence of Cardiovascular Events Following Myocardial Infarction in France: an Observational Analysis Using a Claims Database.

Philippe F, Blin P, Laurendeau C, Bouee S, Gourmelen J, Levy Bachelot L, Leproust S, Steg PG.

Value Health. 2015 Nov;18(7):A382. doi: 10.1016/j.jval.2015.09.817. Epub 2015 Oct 20. No abstract available.

29.

Benefit-Risk of Vka for Atrial Fibrillation Before Doac: a Cohort Study in a Claims and Hospitalization Database.

Blin P, Dureau-Pournin C, Lassalle R, Abouelfath A, Droz-Perroteau C, Moore N.

Value Health. 2015 Nov;18(7):A381. doi: 10.1016/j.jval.2015.09.812. Epub 2015 Oct 20. No abstract available.

30.

A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC.

Blin P, Dureau-Pournin C, Lassalle R, Abouelfath A, Droz-Perroteau C, Moore N.

Br J Clin Pharmacol. 2016 Mar;81(3):569-78. doi: 10.1111/bcp.12807. Epub 2015 Dec 28.

31.

Population genomics reveals additive and replacing horizontal gene transfers in the emerging pathogen Dickeya solani.

Khayi S, Blin P, Pédron J, Chong TM, Chan KG, Moumni M, Hélias V, Van Gijsegem F, Faure D.

BMC Genomics. 2015 Oct 14;16:788. doi: 10.1186/s12864-015-1997-z.

32.

Liver transplant associated with paracetamol overdose: results from the seven-country SALT study.

Gulmez SE, Larrey D, Pageaux GP, Bernuau J, Bissoli F, Horsmans Y, Thorburn D, McCormick PA, Stricker B, Toussi M, Lignot-Maleyran S, Micon S, Hamoud F, Lassalle R, Jové J, Blin P, Moore N.

Br J Clin Pharmacol. 2015 Sep;80(3):599-606. doi: 10.1111/bcp.12635. Epub 2015 May 27.

33.

Antihypertensive drugs, hypotension, and ischemic colitis.

Blin P.

Am J Cardiovasc Drugs. 2015 Apr;15(2):77-9. doi: 10.1007/s40256-015-0112-9. No abstract available.

PMID:
25773018
34.

Parkinson's disease incidence and prevalence assessment in France using the national healthcare insurance database.

Blin P, Dureau-Pournin C, Foubert-Samier A, Grolleau A, Corbillon E, Jové J, Lassalle R, Robinson P, Poutignat N, Droz-Perroteau C, Moore N.

Eur J Neurol. 2015 Mar;22(3):464-71. doi: 10.1111/ene.12592. Epub 2014 Nov 12.

PMID:
25389031
35.

Misuse, Abuse, and Diversion of instanyl® (Fentanyl Nasal Spray) in France.

Blin P, Dureau C, Lamarque S, Bernard MA, Robinson P, Lassalle R, Grolleau A, Droz C, Moore N.

Value Health. 2014 Nov;17(7):A649. doi: 10.1016/j.jval.2014.08.2357. Epub 2014 Oct 26. No abstract available.

36.

The 3.5-Year Mortality Impact Of Drugs In Secondary Prevention Of Myocardial Infarction In Real-Life (Interim Analysis Of The Eole Cohort).

Droz C, Dureau C, Thomas D, Danchin N, Tricoire J, Benichou J, Paillard F, Hercberg S, Sibon I, Rouanet F, Rambelomanana S, Maizi H, Bernard MA, Blin P, Moore N.

Value Health. 2014 Nov;17(7):A476. doi: 10.1016/j.jval.2014.08.1366. Epub 2014 Oct 26. No abstract available.

37.

Type 2 Diabetes Treatment Patterns Across Europe.

Heintjes E, Overbeek JA, Blin P, Hall GC, Lapi F, Prieto AD, Bezemer ID.

Value Health. 2014 Nov;17(7):A359. doi: 10.1016/j.jval.2014.08.779. Epub 2014 Oct 26. No abstract available.

38.

Agrobacterium uses a unique ligand-binding mode for trapping opines and acquiring a competitive advantage in the niche construction on plant host.

Lang J, Vigouroux A, Planamente S, El Sahili A, Blin P, Aumont-Nicaise M, Dessaux Y, Moréra S, Faure D.

PLoS Pathog. 2014 Oct 9;10(10):e1004444. doi: 10.1371/journal.ppat.1004444. eCollection 2014 Oct.

39.

New oral anticoagulants (NOAC) and liver injury.

Moore N, Blin P, Gulmez SE.

J Hepatol. 2014 Aug;61(2):198-9. doi: 10.1016/j.jhep.2014.05.010. Epub 2014 May 15. No abstract available.

40.

Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database.

Sabouret P, Depret-Bixio L, Cotte FE, Marie P, Bedira N, Blin P.

Clin Res Cardiol. 2014 Nov;103(11):887-93. doi: 10.1007/s00392-014-0726-y. Epub 2014 May 15.

PMID:
24830515
41.

Cardiovascular risks associated with low-dose ibuprofen and diclofenac as used OTC.

Moore N, Salvo F, Duong M, Blin P, Pariente A.

Expert Opin Drug Saf. 2014 Feb;13(2):167-79. doi: 10.1517/14740338.2014.846324. Epub 2013 Nov 21. Review.

PMID:
24256349
42.

Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France.

Duong M, Salvo F, Pariente A, Abouelfath A, Lassalle R, Droz C, Blin P, Moore N.

Br J Clin Pharmacol. 2014 May;77(5):887-95. doi: 10.1111/bcp.12239.

43.

Relative risks from case-population data.

Moore N, Gulmez SE, Blin P, Lassalle R, Jove J, Théophile H, Bégaud B, Larrey D, Bénichou J.

Epidemiology. 2013 Nov;24(6):935-6. doi: 10.1097/EDE.0b013e3182a77882. No abstract available.

PMID:
24076997
44.

Pharmacoepidemiology studies: what levels of evidence and how can they be reached?

Lapeyre-Mestre M, Sapède C, Moore N; participants of round table N° 5 of Giens Workshops XXVIII (th), Bilbault P, Blin P, Chopy D, Evans D, Gueyffier F, Lacoin L, Malbezin M, Micallef J, Morlet-Vigier D, Muller S, Oger E, Plétan Y, Pons G, Verpillat P, Vigneau C.

Therapie. 2013 Jul-Aug;68(4):241-52. doi: 10.2515/therapie/2013038. Epub 2013 Aug 28. English, French.

45.

Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?

Lapeyre-Mestre M, Sapède C, Moore N; les participants à la table ronde N° 5 de Giens XXVIII :, Bilbault P, Blin P, Chopy D, Evans D, Gueyffier F, Lacoin L, Malbezin M, Micallef J, Morlet-Vigier D, Muller S, Oger E, Plétan Y, Pons G, Verpillat P, Vigneau C.

Therapie. 2013 Jul-Aug;68(4):241-6. doi: 10.2515/therapie/2013037. French. No abstract available.

PMID:
27392726
46.

Causality of Drugs Involved in Acute Liver Failure Leading to Transplantation: Results from the Study of Acute Liver Transplant (SALT).

Gulmez SE, Moore N, Pageaux GP, Lignot S, Horsmans Y, Stricker B, Bernuau J, Bissoli F, Thorburn D, Montastruc JL, Micon S, Hamoud F, Lassalle R, Jové J, Blin P, Larrey D.

Drug Saf. 2013 Sep;36(9):757-64. doi: 10.1007/s40264-013-0071-5.

PMID:
23743692
47.

Is paracetamol hepatotoxic at normal doses?

Moore ND, Gulmez E, Blin P.

BMJ. 2013 Mar 12;346:f1519. doi: 10.1136/bmj.f1519. No abstract available.

PMID:
23482978
48.

One-year effectiveness of a 3-week balneotherapy program for the treatment of overweight or obesity.

Hanh T, Serog P, Fauconnier J, Batailler P, Mercier F, Roques CF, Blin P.

Evid Based Complement Alternat Med. 2012;2012:150839. doi: 10.1155/2012/150839. Epub 2012 Dec 24.

49.

Transplantation for acute liver failure in patients exposed to NSAIDs or paracetamol (acetaminophen): the multinational case-population SALT study.

Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jové J, Gatta A, McCormick PA, Metselaar HJ, Monteiro E, Thorburn D, Bernal W, Zouboulis-Vafiadis I, de Vries C, Perez-Gutthann S, Sturkenboom M, Bénichou J, Montastruc JL, Horsmans Y, Salvo F, Hamoud F, Micon S, Droz-Perroteau C, Blin P, Moore N.

Drug Saf. 2013 Feb;36(2):135-44. doi: 10.1007/s40264-012-0013-7.

50.

Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in France.

Moore N, Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jové J, Pariente A, Blin P, Bénichou J, Bégaud B.

Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):160-7. doi: 10.1002/pds.3371. Epub 2012 Nov 20.

PMID:
23166053

Supplemental Content

Support Center